Clinical trials
Multiple Sclerosis trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 4 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Active, not recruiting | 6 |
| Terminated | 6 |
| Enrolling by invitation | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Turku University Hospital | 8 |
| Bayer | 7 |
| Novartis Pharmaceuticals | 6 |
| Biogen | 5 |
| Merck KGaA, Darmstadt, Germany | 5 |
| Sanofi | 5 |
| Actelion | 4 |
| Novartis | 3 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Hoffmann-La Roche | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 56 |
| Multiple Sclerosis, Relapsing-Remitting | 10 |
| Multiple Sclerosis, Chronic Progressive | 2 |
| Recurrence | 2 |
| Alzheimer Disease | 1 |
| Deglutition Disorders | 1 |
| Dementia | 1 |
| Demyelinating Diseases | 1 |
| Diffuse Cerebral Sclerosis of Schilder | 1 |
| Disease Progression | 1 |
Trials
Showing 26 to 50 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.